この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Memantine is an <jats:styled-content style="fixed-case">N</jats:styled-content>‐methyl‐<jats:styled-content style="fixed-case">D</jats:styled-content>‐aspartate glutamate receptor antagonist that may improve cognitive functions in patients with <jats:styled-content style="fixed-case">A</jats:styled-content>lzheimer's disease. It is predominantly excreted unchanged via the kidneys, and patients with decreased creatinine clearance must be treated with lower doses of memantine. However, it is unclear whether memantine itself can lead to renal dysfunction and/or hyperkalaemia. We report a patient with renal impairment and hyperkalaemia possibly associated with memantine administration.</jats:p>
収録刊行物
-
- Psychogeriatrics
-
Psychogeriatrics 13 180-181, 2013-09-01
Wiley
